As filed with the Securities and Exchange Commission on October 1, 1999
Registration No. 333-34345
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------
POST EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------
SEROLOGICALS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 58-2142225
(State or other jurisdiction (I.R.S. employer)
of incorporation or organization) identification no.
780 Park North Blvd., Suite 110
Clarkston, Georgia 30021
(404) 296-5595
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
------------
DESMOND H. O'CONNELL, JR.
President and Chief Executive Officer
Serologicals Corporation
780 Park North Blvd., Suite 110
Clarkston, Georgia 30021
(404) 296-5595
(Name, address, including zip code, and telephone number, including area
code, of agent for service)
-----------
Copies to:
DAVID S. ROSENTHAL
Swidler Berlin Shereff Friedman, LLP
919 Third Avenue
New York, New York 10022
(212) 758-9500
The Registrant hereby deregisters 264,100 shares of Common Stock of the
Registrant registered hereunder for resale by:
Franklin Small Cap Growth Fund 225,000
Asarco 500
Wasatch Aggressive Equity Fund 25,100
ACF/CRF Joint Fund 13,500
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Clarkston, State of Georgia, on
this 1st day of October, 1999.
---
SEROLOGICALS CORPORATION
By:/s/ Russell H. Plumb
---------------------------
Russell H. Plumb
Vice President, Finance and
Administration,
Chief Financial Officer and Treasurer
Pursuant to the requirements of the Securities Act of 1933, this
registration statement on Form S-3 has been signed below by the following
persons on behalf of Serologicals Corporation and in the capacities indicated
on October 1, 1999:
Signature Title
/s/ Desmond H. O'Connell, Jr. President, Chief Executive Officer and Director
- -------------------------
Desmond H. O'Connell, Jr.
/s/ Russell H. Plumb Vice President, Finance and Administration,
- ------------------------- Chief Financial Officer and Treasurer (Principal
Russell H. Plumb Financial and Accounting Officer)
* Chairman of the Board of Directors
- -------------------------
Samuel A. Penninger, Jr.
* Director
- -------------------------
James L. Currie
* Director
- -------------------------
George M. Shaw, MD., Ph.D.
* Director
- -------------------------
Lawrence E. Tilton
* Director
- -------------------------
Matthew C. Weisman
Director
- -------------------------
Wade Fetzer, III
- ---------
*By Russell H. Plumb as attorney-in-fact
